Home

Protein List (UniProt Accession)

Small Molecules (DrugBank Accession)

Download

Q07869 PPARA_HUMAN

Gene name: PPARA
Protein name: Peroxisome proliferator-activated receptor alpha

List of molecules and drugs that target protein Q07869
# DrugDomain Data DrugBank Accession Name Drug action Affinity data InChI Key SMILES
1 Q07869_DB00132 DB00132 alpha-Linolenic acid n/a IC50(nM) = 1200.0
Kd(nM) = 7.9
DTOSIQBPPRVQHS-PDBXOOCHSA-N CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
2 Q07869_DB00159 DB00159 Icosapent n/a IC50(nM) = 1100.0
JAZBEHYOTPTENJ-JLNKQSITSA-N CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
3 Q07869_DB00197 DB00197 Troglitazone n/a
GXPHKUHSUJUWKP-UHFFFAOYSA-N CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4 Q07869_DB00313 DB00313 Valproic acid n/a
NIJJYAXOARWZEE-UHFFFAOYSA-N CCCC(CCC)C(O)=O
5 Q07869_DB00328 DB00328 Indomethacin agonist
CGIGDMFJXJATDK-UHFFFAOYSA-N COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
6 Q07869_DB00412 DB00412 Rosiglitazone n/a EC50(nM) = 240.0
YASAKCUCGLMORW-UHFFFAOYSA-N CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
7 Q07869_DB00573 DB00573 Fenoprofen activator
RDJGLLICXDHJDY-UHFFFAOYSA-N CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
8 Q07869_DB00636 DB00636 Clofibrate agonist EC50(nM) = 55000.0
KNHUKKLJHYUCFP-UHFFFAOYSA-N CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
9 Q07869_DB01039 DB01039 Fenofibrate agonist IC50(nM) = 1000.0
EC50(nM) = 2000.0
YMTINGFKWWXKFG-UHFFFAOYSA-N CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
10 Q07869_DB01050 DB01050 Ibuprofen activator
HEFNNWSXXWATRW-UHFFFAOYSA-N CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
11 Q07869_DB01118 DB01118 Amiodarone agonist
IYIKLHRQXLHMJQ-UHFFFAOYSA-N CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
12 Q07869_DB01241 DB01241 Gemfibrozil agonist EC50(nM) = 11800.0
HEMJJKBWTPKOJG-UHFFFAOYSA-N CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
13 Q07869_DB01393 DB01393 Bezafibrate agonist EC50(nM) = 30000.0
IIBYAHWJQTYFKB-UHFFFAOYSA-N CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
14 Q07869_DB01708 DB01708 Prasterone activator
FMGSKLZLMKYGDP-USOAJAOKSA-N [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
15 Q07869_DB01890 DB01890 N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide n/a
OJSUWTDDXLCUFR-HGZMBBKESA-N [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)N(CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
16 Q07869_DB02266 DB02266 Flufenamic acid activator
LPEPZBJOKDYZAD-UHFFFAOYSA-N OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
17 Q07869_DB02709 DB02709 Resveratrol n/a
LUKBXSAWLPMMSZ-OWOJBTEDSA-N OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
18 Q07869_DB02746 DB02746 Phthalic Acid n/a
XNGIFLGASWRNHJ-UHFFFAOYSA-N OC(=O)C1=CC=CC=C1C(O)=O
19 Q07869_DB03017 DB03017 Lauric acid n/a
POULHZVOKOAJMA-UHFFFAOYSA-N CCCCCCCCCCCC(O)=O
20 Q07869_DB03193 DB03193 Stearic acid n/a IC50(nM) = 1100.0
EC50(nM) = 40000.0
QIQXTHQIDYTFRH-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC(O)=O
21 Q07869_DB03756 DB03756 Doconexent activator
MBMBGCFOFBJSGT-KUBAVDMBSA-N CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
22 Q07869_DB03796 DB03796 Palmitic Acid n/a IC50(nM) = 1500.0
EC50(nM) = 35000.0
IPCSVZSSVZVIGE-UHFFFAOYSA-N CCCCCCCCCCCCCCCC(O)=O
23 Q07869_DB04224 DB04224 Oleic Acid n/a
ZQPPMHVWECSIRJ-MDZDMXLPSA-N CCCCCCCC\C=C\CCCCCCCC(O)=O
24 Q07869_DB04519 DB04519 Caprylic acid n/a
WWZKQHOCKIZLMA-UHFFFAOYSA-N CCCCCCCC(O)=O
25 Q07869_DB04557 DB04557 Arachidonic Acid n/a
YZXBAPSDXZZRGB-DOFZRALJSA-N CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
26 Q07869_DB04971 DB04971 Reglitazar n/a
QBQLYIISSRXYKL-UHFFFAOYSA-N CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1
27 Q07869_DB05187 DB05187 Elafibranor n/a
AFLFKFHDSCQHOL-IZZDOVSWSA-N CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1
28 Q07869_DB05416 DB05416 Cardarine agonist IC50(nM) = 463.0
EC50(nM) = 229.0
YDBLKRPLXZNVNB-UHFFFAOYSA-N CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F
29 Q07869_DB06510 DB06510 Muraglitazar n/a
IRLWJILLXJGJTD-UHFFFAOYSA-N COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1
30 Q07869_DB06521 DB06521 Ertiprotafib n/a
FONCZICQWCUXEB-RUZDIDTESA-N CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1
31 Q07869_DB06533 DB06533 Ragaglitazar n/a
WMUIIGVAWPWQAW-XMMPIXPASA-N CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O
32 Q07869_DB06536 DB06536 Tesaglitazar n/a
CXGTZJYQWSUFET-IBGZPJMESA-N CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O
33 Q07869_DB07215 DB07215 GW-590735 n/a Kd(nM) = 170.0
EC50(nM) = 4.0
ILUPZUOBHCUBKB-UHFFFAOYSA-N CC1=C(SC(=N1)C1=CC=C(C=C1)C(F)(F)F)C(=O)NCC1=CC=C(OC(C)(C)C(O)=O)C=C1
34 Q07869_DB07724 DB07724 Indeglitazar n/a
YMPALHOKRBVHOJ-UHFFFAOYSA-N COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
35 Q07869_DB08231 DB08231 Myristic acid n/a IC50(nM) = 5400.0
EC50(nM) = 13000.0
TUNFSRHWOTWDNC-UHFFFAOYSA-N CCCCCCCCCCCCCC(O)=O
36 Q07869_DB08915 DB08915 Aleglitazar agonist IC50(nM) = 38.0
EC50(nM) = 50.0
DAYKLWSKQJBGCS-NRFANRHFSA-N CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O
37 Q07869_DB09006 DB09006 Clinofibrate n/a
BMOVQUBVGICXQN-UHFFFAOYSA-N CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O
38 Q07869_DB09064 DB09064 Ciprofibrate n/a
KPSRODZRAIWAKH-UHFFFAOYSA-N CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O
39 Q07869_DB09213 DB09213 Dexibuprofen n/a
HEFNNWSXXWATRW-JTQLQIEISA-N CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
40 Q07869_DB12007 DB12007 Isoflavone agonist
GOMNOOKGLZYEJT-UHFFFAOYSA-N O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1
41 Q07869_DB12961 DB12961 Leukotriene B4 activator
VNYSSYRCGWBHLG-AMOLWHMGSA-N CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O
42 Q07869_DB13873 DB13873 Fenofibric acid agonist
MQOBSOSZFYZQOK-UHFFFAOYSA-N CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O